Silver Grove Financial Group’s Pulse Biosciences PLSE Stock Holding History

Silver Grove Financial Group’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$83	Buy	+3	New	+$71	﹤0.01%	2356

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Silver Grove Financial Group's PLSE Position: Q2 2026 in Review

Silver Grove Financial Group opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 3 shares worth $83. The stake represents ﹤0.01% of the portfolio and ranks #2356 among its holdings.

106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

Silver Grove Financial Group held 3 shares of Pulse Biosciences worth $83 as of Q2 2026.
Pulse Biosciences was a new Silver Grove Financial Group position in Q2 2026.
Pulse Biosciences made up ﹤0.01% of Silver Grove Financial Group's portfolio in Q2 2026, its #2356 holding.
106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.